NIACINAMIDE 4% / CLOBETASOL PROPIONATE 0.05%- niacinamide 4% / clobetasol propionate 0.05% solution 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

NIACINAMIDE 4% / CLOBETASOL PROPIONATE 0.05%

Directions for use

df

Sincerus Florida, LLC. Adverse reactions

sf

Active, inactive

zcd

NDC 72934- 4154-5 NIACINAMIDE USP 4% / CLOBETASOL PROPIONATE USP 0.05%. Solution 60 gm.

sf

NIACINAMIDE 4% / CLOBETASOL PROPIONATE 0.05% 
niacinamide 4% / clobetasol propionate 0.05% solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-4154
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CLOBETASOL PROPIONATE (UNII: 779619577M) (CLOBETASOL - UNII:ADN79D536H) CLOBETASOL PROPIONATE0.05 g  in 100 g
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE4 g  in 100 g
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-4154-560 g in 1 CYLINDER; Type 0: Not a Combination Product05/20/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/20/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-4154)

Revised: 5/2019
Document Id: 8958565f-7d53-c7a2-e053-2a95a90a77ab
Set id: 8958565f-7d52-c7a2-e053-2a95a90a77ab
Version: 1
Effective Time: 20190520
 
Sincerus Florida, LLC